Skip to main content
  • Jon Juliano Headshot-$3.4-million-grant

    Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa

    Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Read more

  • kovarova-TB-Study.jpg

    Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

    In 2020, more than 1.5 million people around the world died of tuberculosis (TB), marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments. To address that problem, scientists with the UNC Department of Medicine, the UNC Institute for Global Health and Infectious Diseases, and the Internatio … Read more

  • waltmann-meshnick-scaled-e1656101391554-1024x793

    Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

    Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread SP-resistant malaria. Compell … Read more

  • ross-boyce-cdc-renews-funding

    CDC renews five-year funding for vector-borne disease threats

    The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, an … Read more

  • Rutstein Appointed to HIGH IRI Training Program

    Sarah Rutstein, MD, PhD, a physician scientist and senior clinical fellow in the Division of Infectious Diseases in the Department of Medicine, has been accepted to the HIV Infectious Disease and Global Health Implementation Research Institute (HIGH IRI) through the Center for Dissemination and Implementation at the Institute for Public Health at Washington University in St. Loui … Read more

  • fellowship-match-2021-thumbnail

    New Fellows Match to the Department of Medicine

    The National Resident Matching Program released results for the 2021 Medical Specialties Matching Program (MSMP) on December 1.  It is the organization’s largest Fellowship Match comprised primarily of Internal Medicine subspecialties. This year the national program matched more than 7,000 applicants to advanced training positions, the largest number on record. The Department of … Read more

  • Welcome to our 2022-2023 ID fellows!

    We are excited to announce that we have matched 4 physicians to the ID Fellowship for the 2022-2023 academic year! Drs. Briana Castillo, Alex Commanday, John Franzone, and Stephanie Sweitzer will be joining UNC in July. Interests: HIV, HCV, LGBTQIA+ health, and substance use Residency: University of Illinois Chicago Interests: Domestic HIV implementation research Residency: Emory … Read more

  • Sarah Rutstein, MD, PhD

    Rutstein awarded NC TraCS pilot grant for characterizing long-acting injectable antiretroviral therapy

    Third year ID fellow Sarah Rutstein, MD, PhD (co-I Farel, Go, Napravnik) was awarded a $50K pilot grant from the North Carolina Translational and Clinical Sciences Institute (NC TraCS). NC TraCS supports and funds translational research to improve the health of North Carolina communities. The institute’s Translational Research Matched Pilot Program encourages novel clinical and t … Read more

  • dr-jonathan-parr-STD-Awareness

    Parr, Senior Author of Study That Shows Plasmodium Falciparum Evolving to Escape Malaria Rapid Diagnostics in Africa

    A major tool against malaria in Africa has been the use of rapid diagnostic tests, which have been part of the “test-treat-track” strategy in Ethiopia, the second most-populated country in Africa. But researchers studying blood samples from more than 12,000 individuals in Ethiopia now estimate these tests missed nearly 10% of malaria cases caused by the parasite Plasmodium falcip … Read more

  • Jessica Lin, MD, MSCR

    Novel CRISPR-Based Malaria Diagnostic Capable of Plasmodium Detection, Species Differentiation, and Drug-Resistance Genotyping

    CRISPR-based diagnostics are a new class of highly sensitive and specific assays with multiple applications in infectious disease diagnosis. SHERLOCK, or Specific High-Sensitivity Enzymatic Reporter UnLOCKing, is one such CRISPR-based diagnostic that combines recombinase polymerase pre-amplification, CRISPR-RNA base-pairing, and LwCas13a activity for nucleic acid detection. Resea … Read more

  • About five percent of people living in the Democratic Republic of the Congo have hepatitis B virus says Jonathan Parr, MD, MPH.

    Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics

    Jonathan Parr, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in The Scientist about the development of CRISPR diagnostics. Since the start of the COVID-19 pandemic, researchers have been striving to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers based at Harvard Unive … Read more

  • david-wohl-discussing-mandate-removal-ABC 11

    Wohl Discusses Pfizer’s FDA Approval, the Strain On Area Hospitals, the New Covid Variant, and When To Expect a ‘Covid Normalcy’

    Wohl Hopes FDA Approval Will Encourage Vaccinations David Wohl, MD, professor of medicine in the division of infectious diseases, talked with WRAL.com about the FDA giving fully approval to Pfizer’s Covid-19 vaccine. “I think this helps for those people who are on the fence,” said Wohl. “Here’s another reason, another thing to think about in your decision-making and now it is ful … Read more